Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-08-14

Clinical Trial Update: Limited Access Protocol for the Use of Oral Cisapride

View source ↗

Summary

This document notes the completion of a limited access protocol for oral cisapride intended to treat gastroparesis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Propulsid (cisapride)

Snippet

Sponsor: Yale University | Conditions: Gastroparesis | Status: COMPLETED